0001209191-22-036472.txt : 20220613
0001209191-22-036472.hdr.sgml : 20220613
20220613193119
ACCESSION NUMBER: 0001209191-22-036472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220610
FILED AS OF DATE: 20220613
DATE AS OF CHANGE: 20220613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HERSHBERG ROBERT
CENTRAL INDEX KEY: 0001274139
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 221013094
MAIL ADDRESS:
STREET 1: 3005 FIRST AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Silverback Therapeutics, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-456-2900
MAIL ADDRESS:
STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-10
0
0001671858
Silverback Therapeutics, Inc.
SBTX
0001274139
HERSHBERG ROBERT
C/O SILVERBACK THERAPEUTICS, INC.
500 FAIRVIEW AVENUE N, SUITE 600
SEATTLE
WA
98109
1
0
0
0
Stock Option (right to buy)
4.18
2022-06-10
4
A
0
18000
0.00
A
2032-06-09
Common Stock
18000
18000
D
The shares subject to the option vest on the earlier of June 10, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.
/s/ Jeffrey C. Pepe, Attorney-in-Fact
2022-06-13